Quick Answer
Skye Bioscience, Inc. reported Earnings Per Share Diluted of $1.41 (loss) per share for the year ending 2025.
- Skye Bioscience, Inc. showed a decrease of -93.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Skye Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Skye Bioscience, Inc.'s Earnings Per Share Diluted has declined by 729.4%.
- Historical annual values: Fiscal year 2025: $1.41 (loss) per share | Fiscal year 2024: $0.73 (loss) per share | Fiscal year 2023: $5.37 (loss) per share | Fiscal year 2022: $8.77 (loss) per share | Fiscal year 2021: $0.02 (loss) per share | Fiscal year 2020: $0.03 (loss) per share | Fiscal year 2019: $0.05 (loss) per share | Fiscal year 2018: $0.16 (loss) per share | Fiscal year 2017: $0.11 (loss) per share | Fiscal year 2016: $0.17 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: